NCT00781599

Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Nikki Nollen, PhD, MA · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is to estimate the effect of induction support compared to standard care in increasing compliance with Chantix at month 3

Conditions

• Smokers

Interventions

Type	Name	Description
DRUG	Chantix	Chantix 0.5 mg once daily on days 1-3, 0.5 mg twice daily on days 4-7, and 1 mg twice daily on day 8 through end of treatment at month 3
BEHAVIORAL	Adherence Counseling	Induction Support counseling on days 8, 12, 20 and months 1 and 2. Adherence counseling based on the Information-Motivation-Behavioral Skills model of adherence behavioral change.
BEHAVIORAL	Standard Counseling	Visit with counselor on Day 8 to develop a plan to quit smoking. Discuss strategies to quit, risks of continued smoking and discuss strategies for coping with withdrawal and craving.

Timeline

• Start date: 2008-10-01
• Primary completion: 2010-03-01
• Completion: 2010-03-01
• First posted: 2008-10-29
• Last updated: 2012-07-11
• Results posted: 2012-06-27

Locations

1 site across 1 country: United States